ELAN earnings date and last-quarter result: last quarter beat, P/E -50.90. Updated 2026-07-23.
Elanco Animal Health (ELAN) Research Hub
Elanco Animal Health (ELAN) trades on NYSE, US in the Healthcare (Drug Manufacturers - Specialty & Generic) sector. As of 2026-10-26, shares last closed at 22.96 USD (+1.95%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -50.90, market cap 12.89B. This hub links to the full technical, earnings and options research available for ELAN.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Drug Manufacturers - Specialty & Generic) |
|---|---|
| Exchange | NYSE, US |
| Last close | 22.96 USD (+1.95%) |
| 52-week range | 21.62 USD – 26.87 USD |
| Trend regime | Range |
| 14-day RSI | 55.9 (Bullish) |
| Trailing P/E | -50.90 |
| Market cap | 12.89B |
| Dividend yield | 0.00% |
Available research for ELAN
Covered Call on ELAN: how it works, illustrative setup around the real 22.96 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on ELAN: how it works, illustrative setup around the real 22.96 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on ELAN: how it works, illustrative setup around the real 22.96 USD price, max profit/loss, breakeven and when to use it. Educational.
ELAN technical analysis: range, last 22.96 USD, RSI 55.9, 52w range 21.62 USD–26.87 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is ELAN in?
Elanco Animal Health (ELAN) is classified under Healthcare (Drug Manufacturers - Specialty & Generic), listed on NYSE, US.
Is ELAN in an uptrend or downtrend?
As of 2026-10-26, ELAN is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is ELAN's trailing P/E ratio?
ELAN's trailing P/E is -50.90, with a market cap of 12.89B. See the earnings research page for full valuation detail.